Search Results - "Diz, MDPE"

RECOMMENDATION ON THE TREATMENT OF VENOUS THROMBOEMBOLISM IN CANCER PATIENTS AT A BRAZILIAN PUBLIC ONCOLOGICAL INSTITUTION: EDUCATIONAL PLAN by C Rothschild, NL Nedachi, AP Rabelo, PR Souza, GBG Faria, MR Silva, AAGS Brandão, MDPE Diz, J Pereira, V Rocha

“…Background: In October 2018, a recommendation on the management of venous thromboembolism in cancer patients was developed at ICESP-HCFMUSP and included…”
Get full text

PHARMACEUTICAL VIGILANCE AND EDUCATION: THE FIRST 6 MONTHS OF A NEW ANTICOAGULANT AT A BRAZILIAN PUBLIC CANCER INSTITUTE by C Rothschild, AH Sabanai, AAD Santos, CO Sousa, RS Siqueira, TRVF Neves, AAGS Brandão, MDPE Diz, J Pereira, V Rocha

“…Introduction: Instituto do Câncer do Estado de São Paulo (ICESP-HCFMUSP) is a public universitaryoncological hospital, with currently 43 thousand active…”
Get full text

SAFETY AND EFFECTIVENESS OF ANTICOAGULATION BASED ON AN INSTITUTIONAL RECOMMENDATION ON THE MANAGEMENT OF CANCER ASSOCIATED VENOUS THROMBOSIS by C Rothschild, AAGS Brandão, A Duran, AE Zerati, LA Hajjar, GF Saes, CS Bittar, IBSS Costa, SMR Fonseca, MHHDS Rehder, LBO Alves, MDPE Diz, J Pereira, V Rocha

“…Background: Cancer associated venous thrombosis (CAT) can affect 20% of oncologic patients. Its management is challenging due to coexistent risk of bleeding…”
Get full text

Abstract P2-14-06: Characterization of risk factors in breast cancer young adult patients by Encinas, G, Diz, MDPE, Lyra, EC, Katayama, MLH, Pasini, FS, Brentani, MM, Chammas, R, Góes, JCGS, Folgueira, MAAK

“…Background: Breast cancer diagnosis in the age group of 20-34 years represents 4% of breast cancer cases diagnosed at all ages in São Paulo state, Brazil. Risk…”
Get full text

P2-13-07: Prevalence of Germline BRCA1 and BRCA2 Deleterious Mutations in Brazilian Patients with High-Risk of Breast and Ovarian Cancer by Diz, MDPE, Escobar, KA, Guindalini, RSC, Pasini, FS, Snitkoviski, ML, Maistro, S, Hoff, PMG, Federico, MHH

“…Background: Germline mutations in the BRCA1/2 genes account for the majority of hereditary breast ovarian cancer (HBOC). Distribution and prevalence of…”
Get full text

PCN24 DEFINING GUIDELINES ON BRCA MUTATION TESTING AT A MEDICAL ONCOLOGY UNIT—AT AN UNIVERSITY HOSPITAL IN SOUTH-EASTERN BRAZIL by Brentani, A, Diz, MDPE, Maistro, S, Snitcovsky, I, Federico, M

Get full text